ArticleNature communications2021

Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming.

Yao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.